|
Volumn 24, Issue 6, 2003, Pages 473-474
|
Palliative cytostatic treatment of cervical carcinoma
|
Author keywords
Cervical cancer; Cytostatic therapy; Palliative chemotherapy
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CAMPTOTHECIN;
CARBOPLATIN;
CISPLATIN;
CYTOSTATIC AGENT;
DRUG DERIVATIVE;
FLUOROURACIL;
IFOSFAMIDE;
IPROPLATIN;
IRINOTECAN;
MITOMYCIN;
MITOMYCIN C;
PACLITAXEL;
PLATINUM DERIVATIVE;
VINDESINE;
ANEMIA;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
LUNG METASTASIS;
MAJOR CLINICAL STUDY;
MORTALITY;
NAUSEA;
NEPHROTOXICITY;
NEUROTOXICITY;
NEUTROPENIA;
PALLIATIVE THERAPY;
PREDICTION;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SQUAMOUS CELL CARCINOMA;
STATISTICAL SIGNIFICANCE;
SURVIVAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
UTERINE CERVIX CARCINOMA;
UTERINE CERVIX TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CAMPTOTHECIN;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
FEMALE;
HUMANS;
MITOMYCIN;
PACLITAXEL;
PALLIATIVE CARE;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
UTERINE CERVICAL NEOPLASMS;
VINDESINE;
|
EID: 0344444239
PISSN: 03922936
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (5)
|
References (2)
|